{"schema_version":"1","generated_at":"2026-11-04T19:54:57.235Z","data_as_of":null,"url":"https://www.findmykol.com/kol/liana-nikolaenko","json_url":"https://www.findmykol.com/kol/liana-nikolaenko/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"liana-nikolaenko","name":"Liana Nikolaenko","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"City Of Hope National Medical Center","institution_url":"https://www.findmykol.com/institution/city-of-hope","city":"Duarte","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1700124914","orcid":"0000-0003-0542-1712","openalex":"A5001438849"},"summary":"Liana Nikolaenko is a Hematology physician affiliated with City Of Hope National Medical Center. OpenAlex indexes 72 publications with 824 citations (h-index 16).","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":72,"cited_by_count":824,"h_index":16,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":5,"program_years":{"first":2021,"last":null},"rows_total":9,"shown":3,"withheld":6,"rows":[{"payer":"Roche","program_year":2024,"amount_usd":2000.2,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1700124914"},{"payer":"Bayer","program_year":2023,"amount_usd":138079.59,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1700124914"},{"payer":"Bayer","program_year":2022,"amount_usd":276159.18,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1700124914"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1700124914","source":"payments"},"prescribing":{"data_year":2022,"areas_total":4,"areas_shown":3,"areas":[{"area":"Dermatology","share_pct":40.3,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":40.3,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":22.6,"classes_total":1,"classes":[{"class":"Thalidomide Analog","setting":"prescribed","share_pct":22.6,"drugs":[{"name":"Pomalyst","share_pct":100}],"max_beneficiaries":null}]},{"area":"Anti-infectives","share_pct":19.4,"classes_total":1,"classes":[{"class":"Short-acting sulfonamides","setting":"prescribed","share_pct":19.4,"drugs":[{"name":"Sulfamethoxazole-Trimethoprim","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2022,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Novel devimistat results in complete remissions in heavily pretreated Burkitt lymphoma in a phase 2 trial","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025016168","status":"verified"},{"title":"Mosunetuzumab is effective and well tolerated in older patients with relapsed/refractory follicular lymphoma: Subgroup analysis of a phase I/II study","year":2025,"journal":"British Journal of Haematology","source_url":"https://doi.org/10.1111/bjh.70212","status":"verified"},{"title":"143 | REAL‐WORLD OUTCOMES OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) FOR THE TREATMENT OF RICHTER TRANSFORMATION TO LARGE B‐CELL LYMPHOMA (RT‐LBCL)","year":2025,"journal":"Hematological Oncology","source_url":"https://doi.org/10.1002/hon.70093_143","status":"verified"},{"title":"Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma","year":2024,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/j.clml.2024.05.017","status":"verified"},{"title":"Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CAR T-cell therapy","year":2024,"journal":"Frontiers in Immunology","source_url":"https://doi.org/10.3389/fimmu.2024.1419788","status":"verified"}],"source":"works"},"contact":{"address_1":"1500 DUARTE RD","city":"Duarte","state":"CA","zip":"910103012","phone":"626-256-4673","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1700124914","source":"identity"},"similar":[{"name":"Erminia Massarelli","slug":"erminia-massarelli","institution":"City Of Hope National Medical Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/erminia-massarelli","json_url":"https://www.findmykol.com/kol/erminia-massarelli/profile.json"},{"name":"Swetha Thiruvengadam","slug":"swetha-thiruvengadam","institution":"City Of Hope National Medical Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/swetha-thiruvengadam","json_url":"https://www.findmykol.com/kol/swetha-thiruvengadam/profile.json"},{"name":"Yuman Fong","slug":"yuman-fong","institution":"City Of Hope National Medical Center","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/yuman-fong","json_url":"https://www.findmykol.com/kol/yuman-fong/profile.json"},{"name":"Ravi Salgia","slug":"ravi-salgia","institution":"City Of Hope National Medical Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/ravi-salgia","json_url":"https://www.findmykol.com/kol/ravi-salgia/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"},{"name":"Jaroslaw Maciejewski","slug":"jaroslaw-maciejewski","institution":"Cleveland Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/jaroslaw-maciejewski","json_url":"https://www.findmykol.com/kol/jaroslaw-maciejewski/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":6,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2020-11-19","provider_certified":"2020-11-19","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2022}},"methodology_url":"https://www.findmykol.com/about#methodology"}